Your browser doesn't support javascript.
loading
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.
Li, Mingjia; Zhao, Songzhu; Lopez, Gabrielle; Secor, Austin; Das, Parthib; Surya, Nitya; Grogan, Madison; Patel, Sandip; Chakravarthy, Karthik; Miah, Abdul; Spakowicz, Daniel; Tinoco, Gabriel; Li, Zihai; Wei, Lai; He, Kai; Bertino, Erin; Alahmadi, Asrar; Memmott, Regan; Kaufman, Jacob; Shields, Peter G; Carbone, David P; Presley, Carolyn J; Otterson, Gregory A; Owen, Dwight H.
Affiliation
  • Li M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA. Mingjia.Li@OSUMC.EDU.
  • Zhao S; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, USA.
  • Lopez G; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Secor A; College of Medicine, The Ohio State University, Columbus, USA.
  • Das P; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Surya N; College of Medicine, The Ohio State University, Columbus, USA.
  • Grogan M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Patel S; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Chakravarthy K; College of Medicine Medical Scientist Training Program, The Ohio State University, Columbus, USA.
  • Miah A; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA.
  • Spakowicz D; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Tinoco G; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Li Z; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA.
  • Wei L; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • He K; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Bertino E; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA.
  • Alahmadi A; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, USA.
  • Memmott R; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Kaufman J; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA.
  • Shields PG; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Carbone DP; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Presley CJ; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Otterson GA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Owen DH; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA.
Cancer Immunol Immunother ; 72(7): 2067-2074, 2023 Jul.
Article in En | MEDLINE | ID: mdl-36795122
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytosis / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytosis / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Type: Article Affiliation country: United States